Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
Conditions : HIV-1-infection Interventions : Drug: GS-3242 Tablet; Drug: GS-3242 Injection; Drug: Lenacapavir Tablet; Drug: Lenacapavir Injection; Drug: B/F/TAF Sponsors : Gilead Sciences Not yet…
Read the full article2d agoen
Comments
Sign in to join the conversation.
No comments yet. Be the first.